Karen Kaucic
Chief Tech/Sci/R&D Officer bij PPD, INC.
Profiel
Karen Kaucic is Chief Medical Officer & Executive Vice President bij PPD, Inc. Dr. Kaucic is gepromoveerd aan de Ohio State University.
Actieve functies van Karen Kaucic
Bedrijven | Functie | Begin |
---|---|---|
PPD, INC. | Chief Tech/Sci/R&D Officer | - |
Eerdere bekende functies van Karen Kaucic
Bedrijven | Functie | Einde |
---|---|---|
Evidera, Inc.
Evidera, Inc. Miscellaneous Commercial ServicesCommercial Services Evidera, Inc. engages in provision of health economics, outcomes research, market access, data analytics and epidemiology services. It offers software for real-world data analytics, meta research, modeling and simulation, outcomes research, patient preferences, payer communications and strategy, precision and transformative technology solutions, and value and evidence planning. The company was founded in 2013 and is headquartered in Bethesda, MD. | President | - |
Opleiding van Karen Kaucic
The Ohio State University | Doctorate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Bedrijven in privébezit | 2 |
---|---|
Evidera, Inc.
Evidera, Inc. Miscellaneous Commercial ServicesCommercial Services Evidera, Inc. engages in provision of health economics, outcomes research, market access, data analytics and epidemiology services. It offers software for real-world data analytics, meta research, modeling and simulation, outcomes research, patient preferences, payer communications and strategy, precision and transformative technology solutions, and value and evidence planning. The company was founded in 2013 and is headquartered in Bethesda, MD. | Commercial Services |
PPD, Inc.
PPD, Inc. Miscellaneous Commercial ServicesCommercial Services PPD, Inc. engages in the provision of drug development services to the biopharmaceutical industry, focuses on helping customers bring their new medicines to patients around the world. It operates through the Clinical Development Services and Laboratory Services segments. The Clinical Development Services segment focuses in early development/Phase I, patient recruitment and enrollment, investigator site management, Phase II-IV clinical trial management, medical communications and various peri- and post-approval services. The Laboratory Services segment comprises of bioanalytical, vaccine sciences, GMP, central lab and biomarker testing. The company was founded by Fred Eshelma in 1985 and is headquartered in Wilmington, NC. | Commercial Services |